v3.26.1
Segment Information - Schedule of Segment Reporting Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Segment Reporting Information [Line Items]      
Rental revenues (including tenant reimbursements) $ 68,920 $ 71,697  
Other revenues 76 25  
Total revenues 68,996 71,722  
Property expenses (7,576) (7,379)  
Depreciation and amortization expense (18,584) (18,391)  
Impairment loss on real estate 0 (3,527)  
Gain (loss) on sale of real estate 422 0  
Interest and other income 6,331 1,613  
Interest expense (6,431) (4,500)  
Net income 32,809 31,077  
General and administrative expense 10,349 8,461  
Preferred stock dividends (2,654) (781)  
Net income attributable to common stockholders 30,155 30,296  
Segment Total Assets: 2,393,980   $ 2,370,858
Operating Segments      
Segment Reporting Information [Line Items]      
Net income 49,244 43,025  
Operating Segments | Cannabis Portfolio Segment:      
Segment Reporting Information [Line Items]      
Rental revenues (including tenant reimbursements) 68,920 71,697  
Other revenues 76 25  
Total revenues 68,996 71,722  
Property expenses (7,576) (7,379)  
Depreciation and amortization expense (18,584) (18,391)  
Impairment loss on real estate 0 (3,527)  
Gain (loss) on sale of real estate 422 0  
Interest and other income 442 600  
Net income 43,700 43,025  
Segment Total Assets: 2,145,401   2,165,359
Operating Segments | Life Science Portfolio Segment:      
Segment Reporting Information [Line Items]      
Interest and other income 5,544 0  
Net income 5,544 0  
Segment Total Assets: 153,980   152,665
Unallocated:      
Segment Reporting Information [Line Items]      
Interest and other income 345 1,013  
Interest expense (6,431) (4,500)  
Net income 32,809 31,077  
General and administrative expense (10,349) $ (8,461)  
Segment Total Assets: $ 94,599   $ 52,834